| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/06/2002 | CN1338633A Protein chip for diagnosing autoimmune diseases |
| 03/06/2002 | CN1338632A Reagent kit using flow sealing technique for immuno-gold label detection |
| 03/06/2002 | CN1080312C Rapamycin assay |
| 03/06/2002 | CN1080307C Method and system for enhanced production of commercially important exoproteins in grampositive bacteria |
| 03/06/2002 | CN1080305C Preparation of hepatocellular cearcinoma oncogene |
| 03/05/2002 | US6353471 Method and apparatus for non-destructive screening of specimen integrity |
| 03/05/2002 | US6353151 Transgenic model for heart failure |
| 03/05/2002 | US6353129 Water soluble tri-substituted 1,2-dioxetane compounds having increased storage stability, synthetic processes and intermediates |
| 03/05/2002 | US6353093 gidB |
| 03/05/2002 | US6353092 Patched-2 polypeptide |
| 03/05/2002 | US6353089 Stimulating proliferation of cytotoxic lymphocytes cells by exposing a fluid sample with a major histocompatability complex and incubate to allow lysis of the presenting cells |
| 03/05/2002 | US6352975 Methods of treating hypertension and compositions for use therein |
| 03/05/2002 | US6352863 Assay device |
| 03/05/2002 | US6352862 Analytical test device for imuno assays and methods of using same |
| 03/05/2002 | US6352860 Liquid and solid tissue mimicking material for ultrasound phantoms and method of making the same |
| 03/05/2002 | US6352852 Homogenizing human platelets in chaps, chromatography, elution |
| 03/05/2002 | US6352835 Eliminating influence of any reducing substance contained in sample prior to conducting redox reaction by adding tetrazolium compound prior to redox reaction |
| 03/05/2002 | US6352834 Reducing available iron, determining prostate specific antigen (psa) level; evaluation for increase of psa which indicates cancer; chelation |
| 03/05/2002 | US6352833 Methods for discovery of vasoactive compounds for the nitric oxide-cyclic GMP signal pathway |
| 03/05/2002 | US6352832 Anti-CCR2 antibodies and methods of use therefor |
| 03/05/2002 | US6352831 Glycolipid complexes and their uses |
| 03/05/2002 | US6352830 Identify immunosuppressive agents by obtaining cells having a transcription factor and expose the cells to a agent that induces nuclear translocation of the transcription factor; monitor translocation and identify immunosuppressive agents |
| 03/05/2002 | US6352828 Oligonucleotide tags for sorting and identification |
| 03/05/2002 | US6352826 Detection kit to assay antibodies against a retrovirus infections by obtaining a whole blood sample and incubating the sample in a culture medium contianing a mitogen to induce polyclonal activation of peripheral blood mononuclear cells |
| 03/05/2002 | US6352824 Redox reversible bipyridyl-osmium complex conjugates |
| 03/05/2002 | US6352672 Apparatus for measuring the luminescence emitted in a luminescent assay |
| 03/05/2002 | US6352630 Electrochemical system for determining blood coagulation time |
| 03/05/2002 | US6352513 Personal cervical cell collector |
| 03/05/2002 | US6352406 Method for assessing quality of a coating process and assembly therefor |
| 03/05/2002 | US6351992 Device and a measuring method for measuring the extension or contracting properties of filamentous specimens |
| 03/05/2002 | US6351989 Apparatus and method for measuring infiltration flow rate |
| 03/05/2002 | US6351988 Measuring the energy absorbing capacity of a substrate |
| 03/05/2002 | US6351987 Fiber optic pressure sensor for DC pressure and temperature |
| 03/05/2002 | US6351982 Housing for a flammable gas detector |
| 03/05/2002 | CA2356553A1 Identification of a capacitative calcium channel in antigen presenting cells and uses thereof |
| 03/05/2002 | CA2067034C Instrument and method for viscoelasticity measurements |
| 03/05/2002 | CA2027694C Process and apparatus for detecting sensitized leukocyte or antigen |
| 03/05/2002 | CA2004878C Apparatus and method for sequential determination of an analyte in a fluid sample |
| 03/01/2002 | CA2318298A1 7-alkoxycoumarins as cytochrome p450 substrates |
| 02/28/2002 | WO2002017362A2 Doped elongated semiconductors, growing such semiconductors, devices including such semiconductors and fabricating such devices |
| 02/28/2002 | WO2002017219A1 Measuring the velocity of small moving objects such as cells |
| 02/28/2002 | WO2002016952A2 Detecting polymers and polymer fragments |
| 02/28/2002 | WO2002016950A1 Dry powder formulation for protein labeling |
| 02/28/2002 | WO2002016949A1 Diagnosis method of fibrotic disease using biochemical markers |
| 02/28/2002 | WO2002016948A2 High throughput method and kit |
| 02/28/2002 | WO2002016947A2 Methods and kits for separation and detection of proteins in biological samples |
| 02/28/2002 | WO2002016946A2 ORAL FLUID RAPID ASSAY FOR HEPATITIS C VIRUS (HCV) ANTIBODIES USING NON-ANTIBODY LABELING OF IgA MOLECULES RECOGNIZING HCV PEPTIDE EPITOPES |
| 02/28/2002 | WO2002016945A1 Chemical sensor and method of detecting chemical |
| 02/28/2002 | WO2002016943A2 Differential immunoassay |
| 02/28/2002 | WO2002016942A1 Immunoassay method by adherence reaction |
| 02/28/2002 | WO2002016941A2 A combinatorial method for rapid screening of drug delivery formulations |
| 02/28/2002 | WO2002016940A2 Genomics-assisted rapid identification of targets |
| 02/28/2002 | WO2002016939A2 Methods of diagnosis of cancer and screening for cancer modulators |
| 02/28/2002 | WO2002016938A1 Method of screening substance serving as the active ingredient in preventives or remedies for neurodegenerative diseases |
| 02/28/2002 | WO2002016937A1 Method of screening remedy for heart failure |
| 02/28/2002 | WO2002016936A1 Device and method for a local resolution study of cross-linked cells and/or cell systems and a use for the study of active ingredients using a microphysiometer |
| 02/28/2002 | WO2002016935A1 Screening method for discovering auxiliary agents promoting endocytosis |
| 02/28/2002 | WO2002016934A1 Assay for s-nitrosothiol compounds |
| 02/28/2002 | WO2002016933A1 Method and device for determining state of skin surface |
| 02/28/2002 | WO2002016932A1 Method of estimating the properties of a polymer product |
| 02/28/2002 | WO2002016931A1 Measuring relative proportions of dissimilar fluids in a pipe |
| 02/28/2002 | WO2002016930A2 Computer-based modelling of ligand/receptor structures |
| 02/28/2002 | WO2002016929A2 Urokinase peptide structure mimetics |
| 02/28/2002 | WO2002016915A1 Chemical sensor and method of detecting chemical |
| 02/28/2002 | WO2002016904A2 Microfluidic device and method with transport of magnetic particles into and out of wells |
| 02/28/2002 | WO2002016903A2 Microfluidic device and method with trapping of sample in carities having lids that can be opened or closed |
| 02/28/2002 | WO2002016648A2 Methods for external controls for nucleic acid amplification |
| 02/28/2002 | WO2002016643A2 Dna pooling methods for quantitative traits using unrelated populations or sib pairs |
| 02/28/2002 | WO2002016638A1 METHOD FOR IDENTIFYING SUBSTANCES USEFUL FOR TREATING INFLAMMATION USING THE RESPONSE ELEMENT TO THE IλBα ROR RECEPTOR |
| 02/28/2002 | WO2002016636A2 Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders |
| 02/28/2002 | WO2002016635A2 Method for marking chemical substances |
| 02/28/2002 | WO2002016634A1 Methods and compositions for ultra low copy number analyte detection |
| 02/28/2002 | WO2002016632A1 Pharmaceutical compositions comprising a modulator of adamts-1 |
| 02/28/2002 | WO2002016615A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase |
| 02/28/2002 | WO2002016612A2 Genes and proteins, and their uses |
| 02/28/2002 | WO2002016611A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 02/28/2002 | WO2002016605A1 Method of protecting personal information |
| 02/28/2002 | WO2002016598A2 Nucleic acid and corresponding protein named 158p1h4 useful in the treatment and detection of bladder and other cancers |
| 02/28/2002 | WO2002016597A2 Lipid metabolism enzymes |
| 02/28/2002 | WO2002016595A2 Kidney-specific protein |
| 02/28/2002 | WO2002016593A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 02/28/2002 | WO2002016587A2 Microtubule-associated proteins and tubulins |
| 02/28/2002 | WO2002016585A2 Imidazoline receptor homologs |
| 02/28/2002 | WO2002016575A1 METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4 |
| 02/28/2002 | WO2002016571A1 Magnetic particles having lower limit critical solution temperature |
| 02/28/2002 | WO2002016567A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/28/2002 | WO2002016561A2 Mfq-111, a novel human gtpase like protein |
| 02/28/2002 | WO2002016555A2 Htert-immortalised cell lines, their preparation and use |
| 02/28/2002 | WO2002016553A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 02/28/2002 | WO2002016528A1 Magnetic particles and process for producing the same |
| 02/28/2002 | WO2002016433A2 Two receptors of meiosis activating sterols designated sam1a and sam1b |
| 02/28/2002 | WO2002016429A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016427A1 Crystal structure of a ras-pi3k complex |
| 02/28/2002 | WO2002016419A2 Progression suppressed gene 13 (psgen 13) and uses thereof |
| 02/28/2002 | WO2002016417A2 Transgenic animal model for neurodegerative disease and uses thereof |
| 02/28/2002 | WO2002016416A2 Diagnosis and treatment of cardiovascular conditions |
| 02/28/2002 | WO2002016415A2 Identification of a cam-kinase ii inhibitor |
| 02/28/2002 | WO2002016410A2 Peptide selection method |
| 02/28/2002 | WO2002016386A1 Human telomerase rna elements |
| 02/28/2002 | WO2002016385A1 Novel tumor suppressor encoding nucleic acid, ptx1, and methods of use thereof |